News & Publications

WilmerHale advised RunSafe Security, the pioneer of a patented process to immunize software from cyberattacks without developer friction, which announced this week the successful completion of its $12 million Series B financing round.

On August 26, 2024, Butlr Technologies Inc., a physical AI (PAI) startup that uses ceiling-mounted sensors to detect individuals’ body heat to track where a person walks and where they might go next, announced its Series B funding round of $38 million.

On July 23, 2024, Level AI, an artificial intelligence company that specializes in customer experience intelligence and automation, announced that it successfully completed a Series C funding round of $39.4 million. 

On June 5, 2024, Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, announced it has raised $41 million in Series D financing.

WilmerHale advised Monitaur, the premier model governance software company for highly regulated companies and their partners, in its recently announced $6 million Series A funding round.

WilmerHale advised BioCatch, the pioneer of behavioral biometrics intelligence and a global leader in digital fraud detection, in its recently announced investment by Permira Growth Opportunities.

WilmerHale advised Alethea, a leading technology company in disinformation detection and mitigation, in its recently announced closing of a $20M Series B funding round led by GV, with participation from Ballistic Ventures, who led Alethea’s Series A funding in 2022.

WilmerHale Launch is proud to be featured as a resource for first-time and repeat entrepreneurs in Disciplined Entrepreneurship: Startup Tactics. The new book, out today, is authored by renowned entrepreneur and Executive Director of the Martin Trust Center for MIT Entrepreneurship Paul Cheek.

The 2024 M&A Report takes a good look at the global M&A market, covering everything from trends to key insights.

The 2024 Venture Capital Report takes a deep dive into the US venture capital market, covering everything from regional and industry breakdowns to insights on important topics.

The 2024 IPO Report takes a close look at the IPO market and shares useful market metrics and need-to-know information on topics that affect pre-IPO companies.

WilmerHale’s annual IPO, Venture Capital and M&A reports offer detailed insights into market conditions and provide comprehensive statistics and thoughtful analysis.

WilmerHale represented Siolta Therapeutics, Inc., a biotech company developing live biotherapeutics that target the core drivers of disease, in its $12 million Series C Preferred Stock financing. 

In 2023, we served as counsel in more than 150 venture financings raising over $4 billion, including some of the largest and most prominent deals of the year.

On February 8, 2024, Nasdaq Private Market, a leading provider of liquidity solutions to private companies, announced that it had closed its Series B financing.